SA516371717B1 - مشتقات 1، 2- داي هيدرو -3H- بيرولو [1، 2-c] إيميدازول -3- أون مضادة للبكتريا - Google Patents

مشتقات 1، 2- داي هيدرو -3H- بيرولو [1، 2-c] إيميدازول -3- أون مضادة للبكتريا

Info

Publication number
SA516371717B1
SA516371717B1 SA516371717A SA516371717A SA516371717B1 SA 516371717 B1 SA516371717 B1 SA 516371717B1 SA 516371717 A SA516371717 A SA 516371717A SA 516371717 A SA516371717 A SA 516371717A SA 516371717 B1 SA516371717 B1 SA 516371717B1
Authority
SA
Saudi Arabia
Prior art keywords
antibacterial
pyrrolo
imidazol
dihydro
derivatives
Prior art date
Application number
SA516371717A
Other languages
Arabic (ar)
English (en)
Inventor
فيليب بانشاود
جين- كريستوف جاوفين
جين لوك سبيكلين
جين فيليب سوريفيت
جيل شابوكس
كريستيان شيميت
ازيلى مير
Original Assignee
اكتيليون فارماسوتيكالز ال تي دي
ايدورسيا فارماسوتيكالز ليمتد
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by اكتيليون فارماسوتيكالز ال تي دي, ايدورسيا فارماسوتيكالز ليمتد filed Critical اكتيليون فارماسوتيكالز ال تي دي
Publication of SA516371717B1 publication Critical patent/SA516371717B1/ar

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41881,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SA516371717A 2014-03-04 2016-08-23 مشتقات 1، 2- داي هيدرو -3H- بيرولو [1، 2-c] إيميدازول -3- أون مضادة للبكتريا SA516371717B1 (ar)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14157636 2014-03-04
PCT/EP2015/054358 WO2015132228A1 (en) 2014-03-04 2015-03-03 1,2-dihydro-3h-pyrrolo[1,2-c]imidazol-3-one derivatives and their use as antibacterial agents

Publications (1)

Publication Number Publication Date
SA516371717B1 true SA516371717B1 (ar) 2018-10-25

Family

ID=50189621

Family Applications (1)

Application Number Title Priority Date Filing Date
SA516371717A SA516371717B1 (ar) 2014-03-04 2016-08-23 مشتقات 1، 2- داي هيدرو -3H- بيرولو [1، 2-c] إيميدازول -3- أون مضادة للبكتريا

Country Status (31)

Country Link
US (1) US10106544B2 (enExample)
EP (1) EP3114126B1 (enExample)
JP (1) JP6516370B2 (enExample)
KR (1) KR20160127127A (enExample)
CN (1) CN106061977B (enExample)
AR (1) AR099612A1 (enExample)
AU (1) AU2015226250B2 (enExample)
BR (1) BR112016020278A8 (enExample)
CA (1) CA2938383A1 (enExample)
CL (1) CL2016002207A1 (enExample)
CY (1) CY1121362T1 (enExample)
DK (1) DK3114126T3 (enExample)
EA (1) EA030708B1 (enExample)
ES (1) ES2709382T3 (enExample)
HR (1) HRP20190013T1 (enExample)
HU (1) HUE042371T2 (enExample)
IL (1) IL247544A0 (enExample)
LT (1) LT3114126T (enExample)
MA (1) MA39707B1 (enExample)
MX (1) MX2016011380A (enExample)
PH (1) PH12016501699A1 (enExample)
PL (1) PL3114126T3 (enExample)
PT (1) PT3114126T (enExample)
SA (1) SA516371717B1 (enExample)
SG (1) SG11201607304WA (enExample)
SI (1) SI3114126T1 (enExample)
TR (1) TR201900393T4 (enExample)
TW (1) TW201542556A (enExample)
UA (1) UA118868C2 (enExample)
WO (1) WO2015132228A1 (enExample)
ZA (1) ZA201606794B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR097617A1 (es) 2013-09-13 2016-04-06 Actelion Pharmaceuticals Ltd Derivados antibacterianos del 2h-indazol
CA2933604A1 (en) 2013-12-19 2015-06-25 Actelion Pharmaceuticals Ltd Antibacterial 1h-indazole and 1h-indole derivatives
KR20170005105A (ko) 2014-05-16 2017-01-11 액테리온 파마슈티칼 리미티드 항균성 퀴나졸린-4(3h)-온 유도체
AR105646A1 (es) * 2015-08-11 2017-10-25 Actelion Pharmaceuticals Ltd Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida
AU2016314963A1 (en) * 2015-08-28 2018-04-19 Idorsia Pharmaceuticals Ltd Antibacterial annulated pyrrolidin-2-one derivatives
AR105848A1 (es) * 2015-08-31 2017-11-15 Actelion Pharmaceuticals Ltd Derivados heterocíclicos antibacterianos
AR105889A1 (es) 2015-09-03 2017-11-22 Actelion Pharmaceuticals Ltd Compuestos antibacterianos 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituidos
TW201840569A (zh) 2017-03-01 2018-11-16 瑞士商愛杜西亞製藥有限公司 (2r)-n-羥基-4-(6-((1-(2-羥基乙基)氮雜環丁烷-3-基)丁-1,3-二炔-1-基)-3-氧基-1h-吡咯并[1,2-c]咪唑-2(3h)-基)-2-甲基-2-(甲磺醯基)丁醯胺之結晶形式
WO2019038362A1 (en) 2017-08-24 2019-02-28 Idorsia Pharmaceuticals Ltd ANTIBACTERIAL PYRROLOIMIDAZOLONES
WO2019086452A1 (en) 2017-10-31 2019-05-09 Idorsia Pharmaceuticals Ltd Antibacterial heteroaromatic compounds
EP4382527A4 (en) * 2021-08-05 2025-08-20 Zhejiang Hisun Pharm Co Ltd AROMATIC ACETYLENE DERIVATIVE, PROCESS FOR ITS PREPARATION AND USE

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04008893A (es) 2002-03-13 2005-06-20 Array Biopharma Inc Derivados de bencimidazol n3 alquilados como inhibidores de mek.
US7781591B2 (en) 2006-06-13 2010-08-24 Wyeth Llc Substituted 3-cyanopyridines as protein kinase inhibitors
DE102004017930A1 (de) 2004-04-14 2005-11-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
BRPI0518984A2 (pt) 2004-12-10 2008-12-16 Univ Emory anÁlogos de nucleosÍdeo de ciclobutil substituÍdos em 2' e 3' para tratamento de infecÇÕes virais e proliferaÇço celular anormal
JP2008001635A (ja) 2006-06-22 2008-01-10 Toray Ind Inc グリシン誘導体及びその用途
DE102008044132A1 (de) 2008-11-27 2010-06-02 BSH Bosch und Siemens Hausgeräte GmbH Kältegerät mit zweiseitig anschlagbarer Tür
MX2011010523A (es) 2009-04-06 2011-10-28 Daiichi Sankyo Co Ltd Compuesto ciclico que tiene grupo fenilo sustituido.
EP2432468A2 (en) 2009-05-20 2012-03-28 Ardea Biosciences, Inc. Methods of modulating uric acid levels
EP2451790A4 (en) 2009-07-07 2012-12-26 Anthem Biosciences Private Ltd INHIBITORS OF HISTONE DEACETYLASE
JP5671545B2 (ja) * 2009-10-13 2015-02-18 ファイザー・インク 抗菌薬として有用なc結合ヒドロキサム酸誘導体
JP5793766B2 (ja) 2009-12-16 2015-10-14 ファイザー・インク 抗菌剤として有用なn−結合型ヒドロキサム酸誘導体
AR083760A1 (es) 2010-11-10 2013-03-20 Achaogen Inc Agentes antibacterianos y composiciones farmaceuticas
US8853213B2 (en) 2011-01-03 2014-10-07 Hanmi Pharm. Co., Ltd Bicyclic compound for modulating G protein-coupled receptors
AP3336A (en) * 2011-03-07 2015-07-31 Pfizer Fluoro-pyridinone derivatives useful as antibacterial agents
JP2014514299A (ja) 2011-04-08 2014-06-19 ファイザー・インク 抗菌剤として有用なイミダゾール、ピラゾールおよびトリアゾール誘導体
CN103717582B (zh) 2011-04-08 2015-09-30 辉瑞大药厂 用作抗菌剂的异*唑衍生物
US8859559B2 (en) 2011-12-20 2014-10-14 Boehringer Ingelheim International Gmbh Substituted pyrazines and their use in the treatment of disease
WO2013170030A1 (en) 2012-05-09 2013-11-14 Achaogen, Inc. Antibacterial agents
EP2847168A1 (en) * 2012-05-10 2015-03-18 Achaogen, Inc. Antibacterial agents
WO2014165075A1 (en) 2013-03-12 2014-10-09 Achaogen, Inc. Antibacterial agents
AR097617A1 (es) 2013-09-13 2016-04-06 Actelion Pharmaceuticals Ltd Derivados antibacterianos del 2h-indazol
CA2933604A1 (en) 2013-12-19 2015-06-25 Actelion Pharmaceuticals Ltd Antibacterial 1h-indazole and 1h-indole derivatives
KR20170005105A (ko) 2014-05-16 2017-01-11 액테리온 파마슈티칼 리미티드 항균성 퀴나졸린-4(3h)-온 유도체
AR105646A1 (es) 2015-08-11 2017-10-25 Actelion Pharmaceuticals Ltd Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida
AU2016314963A1 (en) 2015-08-28 2018-04-19 Idorsia Pharmaceuticals Ltd Antibacterial annulated pyrrolidin-2-one derivatives
AR105848A1 (es) 2015-08-31 2017-11-15 Actelion Pharmaceuticals Ltd Derivados heterocíclicos antibacterianos
AR105889A1 (es) 2015-09-03 2017-11-22 Actelion Pharmaceuticals Ltd Compuestos antibacterianos 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituidos
EP3386950A1 (en) 2015-12-08 2018-10-17 GlaxoSmithKline Intellectual Property Development Limited Substituted benzazinones as antibacterial compounds

Also Published As

Publication number Publication date
BR112016020278A8 (pt) 2017-12-26
JP6516370B2 (ja) 2019-05-22
EP3114126A1 (en) 2017-01-11
SG11201607304WA (en) 2016-09-29
EA201691775A1 (ru) 2017-03-31
US10106544B2 (en) 2018-10-23
UA118868C2 (uk) 2019-03-25
ES2709382T3 (es) 2019-04-16
CN106061977A (zh) 2016-10-26
AU2015226250B2 (en) 2018-12-13
LT3114126T (lt) 2018-12-27
JP2017508746A (ja) 2017-03-30
DK3114126T3 (en) 2019-02-25
EP3114126B1 (en) 2018-10-31
IL247544A0 (en) 2016-11-30
CN106061977B (zh) 2018-10-26
ZA201606794B (en) 2018-11-28
TR201900393T4 (tr) 2019-02-21
PL3114126T3 (pl) 2019-03-29
TW201542556A (zh) 2015-11-16
MA39707B1 (fr) 2019-01-31
EA030708B1 (ru) 2018-09-28
WO2015132228A1 (en) 2015-09-11
BR112016020278A2 (enExample) 2017-08-15
US20170107223A1 (en) 2017-04-20
HUE042371T2 (hu) 2019-06-28
CA2938383A1 (en) 2015-09-11
AR099612A1 (es) 2016-08-03
CY1121362T1 (el) 2020-05-29
PH12016501699A1 (en) 2016-10-03
SI3114126T1 (sl) 2019-01-31
MX2016011380A (es) 2016-12-07
KR20160127127A (ko) 2016-11-02
MA39707A (fr) 2017-01-11
PT3114126T (pt) 2019-02-06
HRP20190013T1 (hr) 2019-02-22
CL2016002207A1 (es) 2017-03-24
AU2015226250A1 (en) 2016-10-20

Similar Documents

Publication Publication Date Title
SA516371717B1 (ar) مشتقات 1، 2- داي هيدرو -3H- بيرولو [1، 2-c] إيميدازول -3- أون مضادة للبكتريا
UY36544A (es) Derivados de 4h-pirrol[3,2-c]piridin-4-ona
MY179283A (en) Antibacterial 2h-indazole derivatives
TW201613872A (en) IRAK4 inhibiting agents
EA201692219A1 (ru) Способы получения противовирусных соединений
PH12016500643A1 (en) New octahydro - cyclobuta [1,2-c;3,4-c`] dipyrrol -2- yl
PH12018500323A1 (en) Substituted 1,2-dihydro-3h-pyrrolo[1,2-c]imidazol-3-one antibacterial compounds
BR112016029825A2 (pt) composto
UY33993A (es) Análogo macrocíclico de la sangliferina y su método de producción
EA201790016A1 (ru) АНАЛОГ ПИРИДИНО[1,2-a]ПИРИМИДОНА, ПРИМЕНЯЕМЫЙ В КАЧЕСТВЕ ИНГИБИТОРА PI3K
PH12016501349A1 (en) Hydroxy formamide derivatives and their use
MX382724B (es) Formas sólidas de ceftolozano.
SA517381678B1 (ar) مركبات داي هيدرو بيريميدين-2-أون واستخدامها الطبي
EA201890476A1 (ru) ЗАМЕЩЕННЫЕ 1,2-ДИГИДРО-3H-ПИРРОЛО[1,2-c]ИМИДАЗОЛ-3-ОНЫ В КАЧЕСТВЕ АНТИБАКТЕРИАЛЬНЫХ СРЕДСТВ
JOP20190163A1 (ar) منشط nrf2
MX2018014170A (es) Derivados 6-(buta-1,3-diin-1-il)benzo[d]tiazol.
AU2015221431A8 (en) Novel 6,7-dihydro-3H-oxazolo[3,4-a]pyrazine-5,8-dione derivative compounds
UA96860U (xx) Похідні [1,2,4]триазоло[4,3-а]піразину
UA79866U (ru) Применение 2-оксоиндолин-3-глиоксиловой кислоты в качестве средств с антидепрессивным действием